Prevalence of Metabolic Syndrome in elderly Iranian people living in nursing homes
Background: Population aging is accompanied by higher prevalence of MetS, which varies depending on the population studied. The objective this study is to determine prevalence of MetS in Iranian elderly.
Methods: 245 of elderly residents in private nursing house in Tehran (90 men and 155 women) were studied. MS was defined according to National Cholesterol Education Program: Adult Treatment Panel III (NCEP ATP III) criteria. They were evaluated by clinical examination, fasting glucose, fasting insulin, lipid profile and anthropometric measurements - weight, height, waist circumference and systolic and diastolic blood pressure. The prevalence of MetS was estimated by NCEP ATP III.
Result: 57.5% showed normal status while 39.2% have MetS. Analysis of logistic regression in two groups, after adjustment for gender, education, marital and vocation status and smoking habit, showed that the risk of MetS in elderly women 2-fold were higher than men (OR: 2.077, CI: 1.198-3.601 and p = 0.009).
Conclusion: Our study indicates that MetS is highly prevalent in the elderly people particularly among women. These results highlight an immediate action of preventive measures programs for modification of cardio metabolic risk factors in elderly population.
2. Organization WH. Uses and interpretation ofanthropometry in the elderly for the assessment ofphysical status. Interim draft report of nutritionunit Ginebra: World Health Organization, TheSubcommittee on the Elderly. 1992.
3. de Onis M, Habicht J-P. Anthropometric referencedata for international use: recommendations froma World Health Organization Expert Committee.Am J Clin Nutr. 1996;64(4):650-8.
4. Winter JE, MacInnis RJ, Wattanapenpaiboon N,Nowson CA. BMI and all-cause mortality in olderadults: a meta-analysis. Am J Clin Nutr.2014;99(4):875-90.
5. Expert Panel on Detection E. Executive summaryof the Third Report of the National CholesterolEducation Program (NCEP) expert panel ondetection, evaluation, and treatment of high bloodcholesterol in adults (Adult Treatment Panel III).JAMA. 2001;285(19):2486.
6. Delavari A, Forouzanfar MH, Alikhani S,Sharifian A, Kelishadi R. First nationwide studyof the prevalence of the metabolic syndrome andoptimal cutoff points of waist circumference inthe Middle East. Diabetes Care. 2009;32(6):1092-7.
7. Zhao Y, Yan H, Yang R, Li Q, Dang S, Wang Y.Prevalence and determinants of metabolicsyndrome among adults in a rural area ofNorthwest China. PloS One. 2014;9(3):e91578.
8. Moore JX, Chaudhary N, Akinyemiju T. PeerReviewed: Metabolic Syndrome Prevalence byRace/Ethnicity and Sex in the United States,National Health and Nutrition ExaminationSurvey, 1988–2012. Prev Chronic Dis. 2017;14.
9. Maharlouei N, Bellissimo N, Ahmadi S,Lankarani K. Prevalence of metabolic syndromein pre-and postmenopausal Iranian women.Climacteric. 2013;16(5):561-7.
10. Maleki F, Sayehmiri F, Kiani F, Nasiri S.Metabolic syndrome prevalence in Iran: asystematic review and meta-analysis. JKermanshah Univ Med Sci. 2014;18(4):242-50.
11. Carr MC. The emergence of the metabolicsyndrome with menopause. J Clin EndocrinolMetab. 2003;88(6):2404-11.
12. Hadaegh F, Zabetian A, Tohidi M, Ghasemi A,Sheikholeslami F, Azizi F. Prevalence ofmetabolic syndrome by the Adult Treatment PanelIII, International Diabetes Federation, and WorldHealth Organization definitions and theirassociation with coronary heart disease in anelderly Iranian population. Ann Acad MedSingapore. 2009;38(2):142.
13. Kaykhaei M, Hashemi M, Narouie B, ShikhzadehA, Jahantigh M, Shirzaei E, et al. Prevalence ofmetabolic syndrome in adult population fromZahedan, southeast Iran. Iran J Public Health.2012;41(2):70.
14. Sarrafzadegan N, Kelishadi R, Baghaei A, SadriGH, Malekafzali H, Mohammadifard N, et al.Metabolic syndrome: an emerging public healthproblem in Iranian women: Isfahan Healthy HeartProgram. Int J Cardiol. 2008;131(1):90-6.
15. Ghazaly AHAH, El-Moez KM, El Shorbagy MS,El-Nahrery EM. Angiopoietin-2 as a biomarkerfor metabolic syndrome and disease activity inrheumatoid arthritis patients. The EgyptianRheumatologist. 2016;38(1):9-13.
16. Salinas MJH, Bertoli AM, Lema L, Saucedo C,Rosa J, Quintana R, et al. Prevalence andcorrelates of metabolic syndrome in patients withrheumatoid arthritis in Argentina. J ClinRheumatol. 2013;19(8):439-43.
17. Kelishadi R, Alikhani S, Delavari A, Alaedini F,Safaie A, Hojatzadeh E. Obesity and associatedlifestyle behaviours in Iran: findings from the firstnational non-communicable disease risk factorsurveillance survey. Public Health Nutr.2008;11(3):246-51.
18. Khader Y, Bateiha A, El-Khateeb M, Al-ShaikhA, Ajlouni K. High prevalence of the metabolicsyndrome among Northern Jordanians. J DiabetesComplications. 2007;21(4):214-9.
19. Kozan O, Oguz A, Abaci A, Erol C, Ongen Z,Temizhan A, et al. Prevalence of the metabolicsyndrome among Turkish adults. Eur J Clin Nutr.2007;61(4):548.
|Issue||Vol 1, No 4 (Autumn 2015)|
|Metabolic syndrome Elderly NCEP ATPIII Insulin resistance Dyslipidemia|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|